United Kingdom Prospective Diabetes Study (UKPDS): What now or so what?

Diabetes/Metabolism Research and Reviews

Volumn 15, Issue 1, 1999, Pages 65-71

  Leslie, R D G ^a  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

Author keywords

Blood pressure; Diabetes trial; HbA(1c)

Indexed keywords

ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; ATENOLOL; CAPTOPRIL; GLUCOSE; INSULIN; METFORMIN; SULFONYLUREA;

ARTICLE; BLOOD GLUCOSE MONITORING; BLOOD PRESSURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES CONTROL; DIABETIC NEPHROPATHY; DIABETIC OBESITY; DIABETIC RETINOPATHY; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; HYPERTENSION; INSULIN BLOOD LEVEL; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MORTALITY; MULTICENTER STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RISK; STROKE; SURVIVAL; UNITED KINGDOM;

EID: 0033065961     PISSN: 15207552     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1520-7560(199901/02)15:1<65::aid-dmrr3>3.3.co;2-o     Document Type: Article

References (17)

1. Kannel WB, Neaton JD, Wentworth D, et al. Overall and coronary heart disease mortality rates in relation to major risk factors in 325,348 men screened for the MRFIT. Am Heart J 1986; 112: 825-836.
2. Stamler J, Vaccaro O, Neaton JD, Wentworth D. Diabetes, other risk factors, and 12 yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 1993; 16: 434-444.
3. Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 977-986.
4. Deckert T, Feldt-Rasmussen B, Borch-Johnsen K, et al. Albuminuria reflects widespread vascular damage: the Steno hypothesis. Diabetologia 1989; 32: 219-226.
5. University Group Diabetes Program. A study of the effects of hypoglycaemic agents on vascular complications in patients with adult-onset diabetes. Diabetes 1970; 19 (suppl 2): 747-830.
6. Klein R. Hyperglycaemia and microvascular and macrovascular disease in diabetes. Diabetes Care 1995; 18: 258-271.
7. Ohkubo Y, Kishikawa H, Araki E, et al. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin dependent diabetes mellitus: a randomised prospective 6 year study. Diabetes Res Clin Pract 1995; 28: 103-117.
8. UK Prospective Diabetes Study Group. Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352: 837-853.
9. UK Prospective Diabetes Study Group. Effect of intensive blood glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 1998; 352: 854-865.
10. UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ 1998; 317: 703-713.
11. UK Prospective Diabetes Study Group. Efficacy of atenolol and captopril in reducing risk of macro-vascular and microvascular complications in type 2 diabetes: UKPDS 39. BMJ 1998; 317: 713-720.
12. UK Prospective Diabetes Study Group. Cost effectiveness analysis of improved blood pressure control in hypertensive patients with type 2 diabetes: UKPDS 40. BMJ 1998; 317: 720-726.
13. Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: Scandinavian Simvastatin Survival Study (4S). Lancet 1994; 344: 1383-1389.
14. Pyorala K, Pedersen TR, Kjekshus J, Faergeman O, Olsson AG, Thorgeirsson G and the Scandinavian Simvastatin Survival Study (4S) Group. Cholesterol lowering with Simvastatin improves prognosis of diabetic patients with coronary heart disease. Diabetes Care 1997; 20: 614-620.
15. Braunwald E. Shattock lecture - cardiovascular medicine at the turn of the millennium: triumphs, concerns, and opportunities. N Engl J Med 1997; 337: 1360-1369.
16. Colwell JA. Aspirin therapy in diabetes. Diabetes Care 1997; 20: 1767-1771.
17. Turner RC, Millns H, Neil HAW, et al. for the United Kingdom Prospective Diabetes Study Group. Risk factors for coronary artery disease in non-insulin dependent diabetes study (UKPDS 23). BMJ 1998; 316: 823-828.